[1]
E. Lattuada, M. Lanzafame, C. Grosso, and F. Soldani, et al., “Optimal fosamprenavir regimen to prevent lipid abnormalities”, Acta Biomed, vol. 80, no. 3, pp. 200–202, Dec. 2009, Accessed: Feb. 08, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171